These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 24229716

  • 1. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Dec 30; 31 Suppl 6():G1-31. PubMed ID: 24331817
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Dec 31; 31 Suppl 7(Suppl 7):H1-31. PubMed ID: 24332295
    [Abstract] [Full Text] [Related]

  • 5. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep 31; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 6. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O, Roura E, Barchana M, Diaz M, Bornstein J.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [Abstract] [Full Text] [Related]

  • 7. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
    Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J.
    Int J Cancer; 2012 Nov 01; 131(9):1969-82. PubMed ID: 22623137
    [Abstract] [Full Text] [Related]

  • 8. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK.
    J Adolesc Health; 2010 Apr 01; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [Abstract] [Full Text] [Related]

  • 9. Global burden of human papillomavirus and related diseases.
    Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [Abstract] [Full Text] [Related]

  • 10. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
    Bosch FX, Tsu V, Vorsters A, Van Damme P, Kane MA.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F1-11. PubMed ID: 23199951
    [Abstract] [Full Text] [Related]

  • 11. Ten Years of Human Papillomavirus Vaccination in the United States.
    Markowitz LE, Gee J, Chesson H, Stokley S.
    Acad Pediatr; 2018 Mar 20; 18(2S):S3-S10. PubMed ID: 29502635
    [Abstract] [Full Text] [Related]

  • 12. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R, Vaz S, Rebelo T, Figueiredo-Dias M.
    Acta Med Port; 2020 Mar 02; 33(3):198-201. PubMed ID: 32130098
    [Abstract] [Full Text] [Related]

  • 13. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
    Borracci RA, Segal SV, Méndez JH.
    Medicina (B Aires); 2018 Mar 02; 78(5):315-328. PubMed ID: 30285924
    [Abstract] [Full Text] [Related]

  • 14. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.
    J Natl Cancer Inst; 2013 Feb 06; 105(3):175-201. PubMed ID: 23297039
    [Abstract] [Full Text] [Related]

  • 15. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA.
    JAMA Netw Open; 2018 Sep 07; 1(5):e181999. PubMed ID: 30646145
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.
    Luttjeboer J, Westra TA, Wilschut JC, Nijman HW, Daemen T, Postma MJ.
    Vaccine; 2013 Aug 20; 31(37):3922-7. PubMed ID: 23806241
    [Abstract] [Full Text] [Related]

  • 17. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG.
    BMC Cancer; 2019 Jun 11; 19(1):563. PubMed ID: 31185951
    [Abstract] [Full Text] [Related]

  • 18. Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.
    Boiron L, Joura E, Largeron N, Prager B, Uhart M.
    BMC Infect Dis; 2016 Apr 16; 16():153. PubMed ID: 27084683
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.
    Eur J Cancer; 2015 Sep 16; 51(13):1732-41. PubMed ID: 26121913
    [Abstract] [Full Text] [Related]

  • 20. Cancer incidence in Germany attributable to human papillomavirus in 2013.
    Buttmann-Schweiger N, Deleré Y, Klug SJ, Kraywinkel K.
    BMC Cancer; 2017 Oct 16; 17(1):682. PubMed ID: 29037233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.